Impact of antiepileptic drugs on cognitive functions in children and adolescents by unknown
Rossiyskiy Vestnik Perinatologii i Pediatrii 2018 vol.63 N5, pages 130-134
Impact of antiepileptic drugs on cognitive functions in
children and adolescents
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
© The authors team, 2018.All Rights Reserved. The article presents modern points of view on
the assessment of сognitive functions of the children and adolescents with epilepsy who take
antiepileptic drugs (AEDs). The authors compare various AEDs which are used in modern clinical
practice in Russia and abroad, their impact on cognitive functions, discuss the psychometric
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